|
1
|
Ferlay J1, Soerjomataram I, Dikshit R,
Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in globocan 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Saha S, Bardelli A, Buckhaults P,
Velculescu VE, Rago C, St Croix B, Romans KE, Choti MA, Lengauer C,
Kinzler KW, et al: A phosphatase associated with metastasis of
colorectal cancer. Science. 294:1343–1346. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Aidaroos AQ and Zeng Q: PRL-3
phosphatase and cancer metastasis. J Cell Biochem. 111:1087–1098.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang Y, Liu XQ, Rajput A, Geng L, Ongchin
M, Zeng Q, Taylor GS and Wang J: Phosphatase PRL-3 is a direct
regulatory target of TGFbeta in colon cancer metastasis. Cancer
Res. 71:234–244. 2011. View Article : Google Scholar
|
|
5
|
Molleví DG, Aytes A, Padullés L,
Martínez-Iniesta M, Baixeras N, Salazar R, Ramos E, Figueras J,
Capella G and Villanueva A: PRL-3 is essentially overexpressed in
primary colorectal tumours and associates with tumour
aggressiveness. Br J Cancer. 99:1718–1725. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lai W, Chen S, Wu H, Guan Y, Liu L, Zeng
Y, Zhao H, Jiang J and Chu Z: PRL-3 promotes the proliferation of
LoVo cells via the upregulation of KCNN4 channels. Oncol Rep.
26:909–917. 2011.PubMed/NCBI
|
|
7
|
Lai W, Liu L, Zeng Y, Wu H, Xu H, Chen S
and Chu Z: KCNN4 channels participate in the EMT induced by PRL-3
in colorectal cancer. Med Oncol. 30:5662013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu H, Lai W, Zhang Y, Liu L, Luo X, Zeng
Y, Wu H, Lan Q and Chu Z: Tumor-associated macrophage-derived IL-6
and IL-8 enhance invasive activity of lovo cells induced by Prl-3
in a kcnn4 channel-dependent manner. BMC Cancer. 14:3302014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brahimi-Horn MC, Chiche J and Pouysségur
J: Hypoxia signalling controls metabolic demand. Curr Opin Cell
Biol. 19:223–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martins SF, Amorim R, Viana-Pereira M,
Pinheiro C, Costa RF, Silva P, Couto C, Alves S, Fernandes S,
Vilaça S, et al: Significance of glycolytic metabolism-related
protein expression in colorectal cancer, lymph node and hepatic
metastasis. BMC Cancer. 16:5352016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen KY, Liu X, Bu P, Lin CS, Rakhilin N,
Locasale JW and Shen X: A metabolic signature of colon cancer
initiating cells. Conf Proc IEEE Eng Med Biol Soc. 2014:4759–4762.
2014.
|
|
13
|
Erreni M, Mantovani A and Allavena P:
Tumor-associated macrophages (TAM) and inflammation in colorectal
cancer. Cancer Microenviron. 4:141–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu X, Li J, Sun X, Guo Y, Chu D, Wei L, Li
X, Yang G, Liu X, Yao L, et al: Tumor suppressor NDRG2 inhibits
glycolysis and glutaminolysis in colorectal cancer cells by
repressing c-Myc expression. Oncotarget. 6:26161–26176. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Estrella V, Chen T, Lloyd M, Wojtkowiak J,
Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg
JM, Sloane BF, et al: Acidity generated by the tumor
microenvironment drives local invasion. Cancer Res. 73:1524–1535.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wellberg EA, Johnson S, Finlay-Schultz J,
Lewis AS, Terrell KL, Sartorius CA, Abel ED, Muller WJ and Anderson
SM: The glucose transporter GLUT1 is required for ErbB2-induced
mammary tumorigenesis. Breast Cancer Res. 18:1312016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katagiri M, Karasawa H, Takagi K, Nakayama
S, Yabuuchi S, Fujishima F, Naitoh T, Watanabe M, Suzuki T, Unno M,
et al: Hexokinase 2 in colorectal cancer: A potent prognostic
factor associated with glycolysis, proliferation and migration.
Histol Histopathol. 1:117992016.
|
|
18
|
Yang P and Li Z, Fu R, Wu H and Li Z:
Pyruvate kinase M2 facilitates colon cancer cell migration via the
modulation of STAT3 signalling. Cell Signal. 26:1853–1862. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xian ZY, Liu JM, Chen QK, Chen HZ, Ye CJ,
Xue J, Yang HQ, Li JL, Liu XF and Kuang SJ: Inhibition of LDHA
suppresses tumor progression in prostate cancer. Tumour Biol.
36:8093–8100. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Min SH, Kim DM, Heo YS, Kim HM, Kim IC and
Yoo OJ: Downregulation of p53 by phosphatase of regenerating liver
3 is mediated by MDM2 and PIRH2. Life Sci. 86:66–72. 2010.
View Article : Google Scholar
|
|
22
|
Basak S, Jacobs SBR, Krieg AJ, Pathak N,
Zeng Q, Kaldis P, Giaccia AJ and Attardi LD: The
metastasis-associated gene Prl-3 is a p53 target involved in
cell-cycle regulation. Mol Cell. 30:303–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peng L, Xing X, Li W, Qu L, Meng L, Lian
S, Jiang B, Wu J and Shou C: PRL-3 promotes the motility, invasion,
and metastasis of LoVo colon cancer cells through PRL-3-integrin
beta1-ERK1/2 and-MMP2 signaling. Mol Cancer. 8:1102009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ming J, Liu N, Gu Y, Qiu X and Wang EH:
PRL-3 facilitates angiogenesis and metastasis by increasing ERK
phosphorylation and up-regulating the levels and activities of
Rho-A/C in lung cancer. Pathology. 41:118–126. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grivennikov SI and Karin M: Dangerous
liaisons: STAT3 and NF-kappaB collaboration and crosstalk in
cancer. Cytokine Growth Factor Rev. 21:11–19. 2010. View Article : Google Scholar
|
|
27
|
Zumsteg A and Christofori G: Corrupt
policemen: Inflammatory cells promote tumor angiogenesis. Curr Opin
Oncol. 21:60–70. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM
and Zhou BP: Stabilization of snail by NF-kappaB is required for
inflammation-induced cell migration and invasion. Cancer Cell.
15:416–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu Y and Zhou BP: Inflammation: A driving
force speeds cancer metastasis. Cell Cycle. 8:3267–3273. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo JL, Maeda S, Hsu LC, Yagita H and
Karin M: Inhibition of NF-kappaB in cancer cells converts
inflammation- induced tumor growth mediated by TNFalpha to
TRAIL-mediated tumor regression. Cancer Cell. 6:297–305. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Greten FR, Eckmann L, Greten TF, Park JM,
Li ZW, Egan LJ, Kagnoff MF and Karin M: IKKbeta links inflammation
and tumorigenesis in a mouse model of colitis-associated cancer.
Cell. 118:285–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dáňová K, Klapetková A, Kayserová J,
Šedivá A, Špíšek R and Jelínková LP: NF-κB, p38 MAPK, ERK1/2, mTOR,
STAT3 and increased glycolysis regulate stability of
paricalcitol/dexamethasone-generated tolerogenic dendritic cells in
the inflammatory environment. Oncotarget. 16:14123–14138. 2015.
View Article : Google Scholar
|
|
34
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Williams AC, Collard TJ and Paraskeva C:
An acidic environment leads to p53 dependent induction of apoptosis
in human adenoma and carcinoma cell lines: Implications for clonal
selection during colorectal carcinogenesis. Oncogene. 18:3199–3204.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Baumann F, Leukel P, Doerfelt A, Beier CP,
Dettmer K, Oefner PJ, Kastenberger M, Kreutz M, Nickl-Jockschat T,
Bogdahn U, et al: Lactate promotes glioma migration by
TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro
Oncol. 11:368–380. 2009. View Article : Google Scholar :
|
|
37
|
Ito S, Fukusato T, Nemoto T, Sekihara H,
Seyama Y and Kubota S: Coexpression of glucose transporter 1 and
matrix metalloproteinase-2 in human cancers. J Natl Cancer Inst.
94:1080–1091. 2002. View Article : Google Scholar : PubMed/NCBI
|
